NVCR compared with NPCE: revenue, margins and what each company keeps, and the suppliers and customers both name

NVCRNovoCure Ltd

Mkt capRevenueRevenue

NPCENeuroPace Inc

Mkt capRevenueRevenue

Compare

NVCRNovoCure Ltd

NPCENeuroPace Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NVCR 3

ZLABZai Labcustomer

—Zai Lab (Shanghai)unlistedcustomer

—Zaiunlistedcustomer

Shared 0

No shared counterparties.

Only NPCE 4

—DIXI Medical USAunlistedsupplier

GBCIGreatbatchsupplier

—Micro Systems Technologies Managementunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Rapport Therapeutics

unlistedcustomer

NVCRNovoCure Ltd

13.14▲+0.23%· post 13.14

Mkt cap$1.5BRevenue$193MQ3 FY26Revenue$655MFY25

NPCENeuroPace Inc

12.28▼−5.61%· post 12.28

ClosedOct 30 '26

Mkt cap$422.2MRevenue$23MQ2 FY26Revenue$96MFY25

Compare

ClosedOct 30 '26

NVCRNovoCure Ltd

NPCENeuroPace Inc

13.14▲+0.23%post 13.14

Price

12.28▼−5.61%post 12.28

$1.5B

Mkt cap

$422.2M

Q3 FY26$193M

Revenue

$23MQ2 FY26

FY25$655M

Revenue

$96MFY25

NVCR13.14▲+0.23%vsNPCE12.28▼−5.61%ClosedOct 30 '26